Artgen Biotech PJSC (MOEX:ISKJ)

Artgen Biotech PJSC Ratios and Metrics

Market cap in millions RUB. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 7, 2022	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	4,287	4,401	4,419	4,287	8,272	2,747
Market Cap Growth	-0.41%	-0.41%	3.10%	-48.18%	201.10%	193.76%
Enterprise Value	4,936	5,317	5,296	5,060	8,928	3,367
Last Close Price	59.54	59.54	59.54	59.54	114.90	38.16
PE Ratio	25.67	20.48	26.17	92.95	711.21	37.71
PS Ratio	2.82	2.89	3.23	3.77	7.01	2.53
PB Ratio	3.99	4.10	4.53	7.52	17.96	6.62
P/TBV Ratio	72.10	74.03	17.75	22.45	77.90	35.53
P/FCF Ratio	11.22	11.52	19.17	50.80	64.88	-
P/OCF Ratio	8.90	9.13	10.16	19.46	29.46	51.01
EV/Sales Ratio	3.24	3.50	3.87	4.45	7.56	3.11
EV/EBITDA Ratio	12.97	15.00	16.32	36.80	47.29	13.42
EV/EBIT Ratio	16.67	17.75	19.23	51.92	68.45	17.01
EV/FCF Ratio	12.92	13.91	22.97	59.97	70.02	-
Debt / Equity Ratio	0.69	0.69	0.81	1.46	1.34	1.18
Debt / EBITDA Ratio	1.92	1.92	2.27	5.51	2.94	1.81
Debt / FCF Ratio	1.93	1.93	3.41	9.86	4.84	-
Asset Turnover	0.58	0.58	0.60	0.60	0.73	0.75
Inventory Turnover	1.86	1.86	1.75	1.99	1.93	1.91
Quick Ratio	1.40	1.40	1.30	0.90	0.81	0.43
Current Ratio	2.29	2.29	1.99	1.74	1.77	1.04
Return on Equity (ROE)	23.55%	23.55%	25.20%	4.48%	7.66%	26.32%
Return on Assets (ROA)	7.18%	7.18%	7.50%	3.22%	5.02%	8.50%
Return on Capital (ROIC)	10.48%	10.48%	10.88%	4.91%	8.23%	14.57%
Return on Capital Employed (ROCE)	13.60%	13.60%	13.90%	5.90%	9.60%	20.70%
Earnings Yield	5.01%	4.88%	3.82%	1.08%	0.14%	2.65%
FCF Yield	8.92%	8.68%	5.22%	1.97%	1.54%	-1.16%
Dividend Yield	-	-	2.02%	1.68%	-	-
Payout Ratio	65.46%	65.46%	61.72%	-	-	-
Buyback Yield / Dilution	-	-	-6.60%	-8.64%	-6.67%	-
Total Shareholder Return	-	-	-4.58%	-6.96%	-6.67%	-

Updated Sep 5, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.